Advanced search
Publication Cover
Expert Opinion on Medical Diagnostics Volume 2, 2008 - Issue 6
Journal homepage
25
Views
0
CrossRef citations to date
0
Altmetric
Review

Genetic predictors of renal failure

Monika Buraczynska Professor of Medical Sciences Medical University of Lublin, Laboratory for DNA Analysis and Molecular Diagnostics, Department of Nephrology, Dr K Jaczewskiego 8, 20-954 Lublin, Poland +48 81 7244 716; +48 81 7244 716; [email protected]
, MD PhD
Pages 651-664 | Published online: 04 Jun 2008

Bibliography

  • Coresh J, Wei GL, McQuillan G, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988 – 1994). Arch Intern Med 2001;161:1207-16
  • Satko SG, Freedman BI, Moossavi S. Genetic factors in end-stage renal disease. Kidney Int 2005;67(Suppl 94):S46-49
  • Locatelli F, Del Vecchio L, Andrulli S, et al. The role of underlying nephropathy in the progression of renal disease. Kidney Int 2000;57(Suppl 75):S49-55
  • Lango H, Weedon MN. What will whole genome search for susceptibility genes for common complex disease offer to clinical practice? J Intern Med 2008;263:16-27
  • Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291:1304-51
  • Altshuler D, Brooks LD, Chakravarti A, et al. A haplotype map of the human genome. Nature 2005;437:1299-320
  • Freedman BI. Genetic factors in common complex renal and cardiovascular diseases. Adv Chronic Kidney Dis 2006;13:105-9
  • Balakrishnan VS, Rao M. Genetics and reverse epidemiology among patients on chronic hemodialysis. Semin Dial 2007;20:570-6
  • Freedman BI. Familial aggregation of end-stage renal failure: aetiological implications. Nephrol Dial Transplant 1999;14:295-7
  • Adler S. Renal disease: environment, race or genes? Ethn Dis 2006;16:S235-39
  • Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001;2:91-9
  • Hinds DA, Stuve LL, Nilsen GB, et al. Whole-genome patterns of common DNA variation in three human populations. Science 2005;307:1072-9
  • Reich DE, Gabriel SB, Altshuler D. Quality and completeness of SNP databases. Nat Genet 2003;33:457-8
  • Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993;52:506-16
  • Bowden DW. Genetics of kidney disease. Kidney Int Suppl 2003;83:S8-12
  • Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. Mapping complex disease loci in whole-genome association studies. Nature 2004;429:446-52
  • Wang WY, Barratt BJ, Clayton DG, Todd JA. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005;6:109-18
  • Kirby J, Heath PR, Shaw PJ, Hamdy FC. Gene expression assays. Adv Clin Chem 2007;44:247-92
  • Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996;334:1448-60
  • Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002;39:930-6
  • Jaber BL, Pereira BJG, Bonventre JV, Balakrishnan VS. Polymorphism of host response genes: implications in the pathogenesis and treatment of acute renal failure. Kidney Int 2005;67:14-33
  • Treszl A, Toth-Heyn P, Kocsis I, et al. Interleukin genetic variants and the risk of renal failure in infants with infection. Pediatr Nephrol 2002;17:713-7
  • Jaber BL, Rao M, Guo D, et al. Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine 2004;25:212-9
  • Fekete A, Treszl A, Toth-Heyn P, et al. Association between heat shock protein 72 gene polymorphism and acute renal failure in premature neonates. Pediatr Res 2003;54:452-5
  • Dikow R, Ritz E. Cardiovascular complications in the diabetic patient with renal disease: an update in 2003. Nephrol Dial Transplant 2003;18:1993-8
  • Foley RN, Collins AJ. End-stage renal disease in the United States: an update from the United States Renal Data System. J Am Soc Nephrol 2007;18:2644-8
  • Chowdhury TA, Dyer PH, Kumar S, et al. Genetic determinants of diabetic nephropathy. Clin Sci Colch 1999;96:221-30
  • Ng DP, Krolewski AS. Molecular genetic approaches for studying the etiology of diabetic nephropathy. Curr Mol Med 2005;5:509-25
  • Jones CA, Krolewski AS, Rogus J, et al. Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney Int 2005;67:1684-91
  • Freedman BI, Bostrom M, Daeihagh P, Bowden DW. Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol 2007;2:1306-16
  • Satko SG, Sedor JR, Iyengar SK, Freedman BI. Familial clustering of chronic kidney disease. Semin Dial 2007;20:229-36
  • Quinn M, Angelico MC, Warram JH, Krolewski AS. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996;39:940-5
  • Freedman BI, Volkova NV, Satko SG, et al. Population-based screening for family history of end-stage renal disease among incident dialysis patients. Am J Nephrol 2005;25:529-35
  • Fogarty DG, Hanna LS, Wantman M, et al. Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes 2000;49:1057-63
  • Schmidt S, Ritz E. Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes. Nephrol Dial Transplant 1997;12(Suppl 2):37-41
  • Schmidt S, Strojek K, Grzeszczak W, et al. Excess of DD homozygotes in haemodialysed patients with type II diabetes. The Diabetic Nephropathy Study Group. Nephrol Dial Transplant 1997;12:427-9
  • Fujisawa T, Ikegami H, Kawaguchi Y, et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 1998;41:47-53
  • Hadjadj S, Tarnow L, Forsblom C, et al. Association between angiotensin-converting enzyme gene polymorphisms and diabetic nephropathy: case-control. haplotype, and family-based study in three European populations. J Am Soc Nephrol 2007;18:1284-91
  • Rogus JJ, Moczulski D, Freire MB, et al. Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study. Hypertension 1998;31:627-31
  • Osawa N, Koya D, Araki S, et al. Combinational effect of genes for the renin-angiotensin system in conferring susceptibility to diabetic nephropathy. J Hum Genet 2007;52:143-51
  • Tomino Y, Makita Y, Shike T, et al. Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients. Nephron 1999;82:139-44
  • Van Ittersum FJ, de Man AM, Thijssen S, et al. Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. Nephrol Dial Transplant 2000;15:1000-7
  • Yamamoto T, Nakamura T, Noble NA, et al. Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 1993;90:1814-8
  • Moczulski DK, Burak W, Doria A, et al. The role of aldose reductase gene in the susceptibility to diabetic nephropathy in type II (non-insulin-dependent) diabetes mellitus. Diabetologia 1999;42:94-7
  • Ng DP, Conn J, Chung SS, Larkins RG. Aldose reductase (AC) (n) microsatellite polymorphism and diabetic microvascular complications in Caucasian type 1 diabetes mellitus. Diabetes Res Clin Pract 2001;52:21-7
  • Neamat-Allah M, Feeney SA, Savage DA, et al. Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in type 1 and type 2 diabetes mellitus. Diabet Med 2001;18:906-14
  • Bain SC, Chowdhury TA. Genetics of diabetic nephropathy and microalbuminuria. J R Soc Med 2000;93:62-6
  • Araki S, Moczulski DK, Hanna L, et al. APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes, results of case-control and family-based studies. Diabetes 2000;49:2190-5
  • Eto M, Saito M, Okada M, et al. Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients. Am J Kidney Dis 2002;40:243-51
  • Leiva E, Mujica V, Elematore I, et al. Relationship between apolipoprotein E polymorphism and nephropathy in type-2 diabetic patients. Diabetes Res Clin Pract 2007;78:196-201
  • Freire MB, Ji L, Onuma T, et al. Gene-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. Hypertension 1998;31:896-9
  • Lovati E, Richard A, Frey BM, et al. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Kidney Int 2001;60:46-54
  • Ng DP, Tai BC, Koh D, et al. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 2005;48:1008-16
  • Moczulski DK, Rogus JJ, Antonellis A, et al. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 1998;47:1164-9
  • Imperatore G, Hanson RL, Pettitt DJ, et al. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes 1998;47:821-30
  • Vardarli I, Baier LJ, Hanson RL, et al. Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 2002;62:2176-83
  • Bowden DW, Sale M, Howard TD, et al. Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib-pairs with a history of diabetic nephropathy. Diabetes 1997;46:882-6
  • Osterholm AM, He B, Pitkaniemi J, et al. Genome-wide scan for type 1 diabetic nephropathy in the Finnish population reveals suggestive linkage to a single locus on chromosome 3q. Kidney Int 2007;71:140-5
  • Ewens KG, George RA, Sharma K, et al. Assessment of 115 candidate genes for diabetic nephropathy by transmission/disequilibrium test. Diabetes 2005;54:3305-18
  • Bowden DW, Colicigno CJ, Langefeld CD, et al. A genome scan for diabetic nephropathy in African Americans. Kidney Int 2004;66:1517-26
  • Vionnet N, Tregouet D, Kazeem G, et al. Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association wit a variant in the promoter region of the adiponectin gene. Diabetes 2006;55:3166-74
  • Iyengar SK, Fox KA, Schlarchere M, et al. Linkage analysis of candidate loci for end-stage renal disease due to diabetic nephropathy. J Am Soc Nephrol 2003;14:S195-201
  • Iyengar SK, Abboud HE, Goddard KA, et al. Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: The Family Investigation of Nephropathy and Diabetes (FIND). Diabetes 2007;56:1577-85
  • Krolewski AS, Poznik GD, Placha G, et al. A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int 2006;69:129-36
  • Placha G, Poznik GD, Dunn J, et al. A genome-wide linkage scan for genes controlling variation in renal function estimated by serum cystatin C levels in extended families with type 2 diabetes. Diabetes 2006;55:3358-65
  • Freedman BI, Hicks PJ, Sale MM, et al. A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans. Nephrol Dial Transplant 2007;22:1131-5
  • Tanaka N, Babazono T, Saito S, et al. Association of solute carrier family 12 (sodium/chloride) member 3 with diabetic nephropathy, identified by genome-wide analyses of single nucleotide polymorphisms. Diabetes 2003;52:2848-53
  • Shimazaki A, Kawamura Y, Kanazawa A, et al. Genetic variations in the gene encoding ELMO1 are associated with susceptibility to diabetic nephropathy. Diabetes 2005;54:1171-8
  • McKnight AJ, Maxwell AP, Sawcer S, et al. A genome-wide DNA microsatellite association screen to identify chromosomal regions harboring candidate genes in diabetic nephropathy. J Am Soc Nephrol 2006;17:831-6
  • Freedman BI, Rich SS, Yu H, et al. Linkage heterogeneity of end-stage renal disease on human chromosome 10. Kidney Int 2002;62:770-7
  • Hanson RL, Craig DW, Millis MP, et al. Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes 2007;56:975-83
  • Donadio JV, Grande JP. IgA nephropathy. N Engl J Med 2002;347:738-48
  • Ji S, Liu M, Chen J, et al. The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation. Clin Transplant 2004;18:536-40
  • Scolari F. Familial IgA nephropathy. J Nephrol 1999;12:213-9
  • Schena FP, Scivittaro V, Ranieri E, et al. Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy. Clin Exp Immunol 1993;92:139-44
  • Hsu SI, Ramirez SB, Winn MP, et al. Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int 2000;57:1818-35
  • Gharavi AG, Yan Y, Scolari F, et al. IgA nephropathy, the most common cause of glomerulonephritis is linked to 6q 22-23. Nat Genet 2000;26:354-7
  • Bisceglia L, Cerullo G, Forabosco P, et al. On behalf of the European IgA Nephropathy Consortium. Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. Am J Hum Genet 2006;79:1130-4
  • Preston GA, Waga I, Alcorta DA. Gene expression profiles of circulating leukocytes correlate with renal disease activity in IgA nephropathy. Kidney Int 2004;65:420-30
  • Takei T, Iida A, Nitta K, et al. Association between single-nucleotide polymorphisms in selectin genes and immunoglobulin A nephropathy. Am J Hum Genet 2002;70:781-6
  • Akiyama F, Tanaka T, Yamada R, et al. Single-nucleotide polymorphisms in the class II region of the major histocompatibility complex in Japanese patients with immunoglobulin A nephropathy. J Hum genet 2002;47:532-8
  • Tuglular S, Berthoux P, Berthoux F. Polymorphisms of the tumor necrosis factor alpha gene at position -308 and TNFd microsatellite in primary IgA nephropathy. Nephrol Dial Transplant 2003;18:724-31
  • Masutani K, Miyake K, Nakashima H, et al. Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients. Am J Kidney Dis 2003;41:371-9
  • Schena FP, Cerullo G, Torres DD, et al. On behalf of the European IgA Nephropathy Consortium. Role of interferon-gamma gene polymorphisms in susceptibility to IgA nephropathy: a family-based association study. Eur J Hum Genet 2006;14:488-96
  • Li YJ, Du Y, Li CX, et al. Family-based association study showing that immunoglobulin A nephropathy is associated with the polymorphisms 2093C and 2180T in the 3´ untranslated region of the Megsin gene. J Am Soc Nephrol 2004;15:1739-43
  • Carturan S, Roccatello D, Menegatti E, et al. Association between transforming growth factor beta 1 gene polymorphisms and IgA nephropathy. J Nephrol 2004;17:786-93
  • Ohtsubo S, Iida A, Nitta K, et al. Association of a single nucleotide polymorphism in the immunoglobulin mu-binding protein 2 gene with immunoglobulin A nephropathy. J Hum Genet 2005;50:30-5
  • Stenvinkel P. Inflammation in end-stage renal disease - a fire that burns within. Contrib Nephrol 2005;149:185-99
  • Rao M, Wong C, Kanetsky P, et al. Cytokine gene polymorphism and progression of renal and cardiovascular diseases. Kidney Int 2007;72:549-56
  • Stenvinkel P, Pecoits-Filho R, Lindholm B; for the DialGene Consortium. Gene polymorphism association studies in dialysis: The nutrition-inflammation axis. Semin Dial 2005;18:322-30
  • Barksby HE, Lea SR, Preshaw PM, Taylor JJ. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol 2007;149:217-25
  • Blakemore AI, Cox A, Gonzalez AM, et al. Interleukin-1 receptor antagonist allele associated with nephropathy in diabetes mellitus. Hum Genet 1996;97:369-74
  • Loughrey BV, Maxwell AP, Fogarty DG, et al. An interleukin 1β allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy. Cytokine 1998;10:984-8
  • Shu KH, Lee SH, Cheng CH, et al. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-α gene polymorphism on IgA nephropathy. Kidney Int 2000;58:783-9
  • Buraczynska M, Ksiazek P, Kubit P, Zaluska W. Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure. Cytokine 2006;36:167-72
  • Losito A, Kalidas K, Santoni S, Jeffery S. Association of interleukin-6 -174 G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients. Kidney Int 2003;64:616-22
  • Rao M, Guo D, Perianayagam MC, et al. Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2005;45:324-33
  • Liu Y, Berthier-Schaad Y, Fallin MD, et al. IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J Am Soc Nephrol 2006;17:863-70
  • Kitamura A, Hasegawa G, Obayashi H, et al. Interleukin-6 polymorphism (-634 C/G) in the promoter region and the progression of diabetic nephropathy in type 2 diabetes. Diabet Med 2002;19:1000-5
  • Buraczynska M, Jozwiak L, Ksiazek P, et al. Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis. Transl Res 2007;150:101-5
  • Girndt M, Kaul H, Sester U, et al. Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 2002;62:949-55
  • Kahraman S, Yilmaz R, Arici M, et al. IL-10 genotype predicts serum levels of adhesion molecules, inflammation and atherosclerosis in hemodialysis patients. J Nephrol 2006;19:50-6
  • Klahr S, Morrissey JJ. The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease. Kidney Int 2000;57(Suppl 75):S-7-14
  • Descamps-Latscha B, Herbelin A, Nguyen AT, et al. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells and monocytes. J Immunol 1995;154:882-92
  • Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-9
  • Thibaudin D, Thibaudin L, Berthoux P, et al. TNFA2 and d2 alleles of the tumor necrosis factor alpha gene polymorphism are associated with onset/occurrence of idiopathic membranous nephropathy. Kidney Int 2007;71:431-7
  • Rao M, Guo D, Jaber BL, et al. Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients. Kidney Int 2004;66:419-27
  • Pritchard JK, Rosenberg NA. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 1999;65:220-8
  • Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003;361:598-604
  • Ardlie KG, Lunetta KL, Seielstad M. Testing for population subdivision and association in four case-control studies. Am J Hum Genet 2002;71:304-11
  • Freedman ML, et al. Assessing the impact of population stratification on genetic associations studies. Nat Genet 2004;36:388-93
  • Epstein MP, Allen AS, Satten GA. A simple and improved correction for population stratification in case-control studies. Am J Hum Genet 2007;80:921-30
  • Smith MW, Patterson N, Lautenberger JA, et al. A high density admixture map for disease gene discovery in African Americans. Am J Hum Genet 2004;74:1001-13
  • Schelling JR, El-Meanawy MA, Barathan S, et al. Generation of kidney transcriptomes using serial analysis of gene expression. Exp Nephrol 2002;10:82-92
  • Chabardes-Garonne D, Mejean A, Aude JC, et al. A panoramic view of gene expression in the human kidney. Proc Natl Acad Sci USA 2003;100:13710-5
  • Gene Expression Omnibus. Available from: www.ncbi.nlm.nih.gov/geo
  • Eikmans M, Baelde HJ, De Heer E, Bruijn JA. RNA expression profiling as prognostic tool in renal patients. Toward nephrogenomics. Kidney Int 2002;62:1125-35
  • Yoshida T, Tang SS, Hsiao LL, et al. Global analysis of gene expression in renal ischemia-reperfusion in mouse. Biochem Biophys Res Commun 2002;291:787-94
  • Alexander JJ, Saxena AK, Bao L, et al. Prominent renal expression of a murine leukemia retrovirus in experimental lupus erythematosus. J Am Soc Nephrol 2002;13:2869-77
  • Kretzler M, Cohen CD, Doran P, et al. Repuncturing the renal biopsy: strategies for molecular diagnosis in nephrology. J Am Soc Nephrol 2002;13:1961-72
  • Lim CS, Zheng S, Kim YS, et al. Th1/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephropathy. Nephrol Dial Transplant 2001;16:269-75
  • Fox GS, Yang Q, Cupples LA, et al. Genomewide linkage analysis to serum creatinine, GFR and creatinine clearance in a community-based population: The Framingham Heart Study. J Am Soc nephrol 2004;15:2457-61
  • Hunt SC, Coon H, Hassteed SJ, et al. Linkage of serum creatinine and glomerular filtration rate to chromosome 2 in Utah pedigrees. Am J Hypertens 2004;17:511-5
  • Langefeld CD, Beck SR, Bowden DW, et al. Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney dis 2004;43:796-800
  • Schelling JR, Abboud HE, Nicholas SB, et al. Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations. The family investigation of nephropathy and diabetes (FIND). Diabetes 2008;57:235-43
  • Krolewski AS, Poznik GD, Placha G, et al. A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int 2006;69:129-36
  • Nagase S, Suzuki H, Wang Y, et al. Association of ecNOS gene polymorphisms with end-stage renal disease. Mol Cell Biochem 2003;244:113-8
  • Moon JY, Jeong L, Lee S, et al. Association of polymorphisms in monocyte chemoattractant protein-1 promoter with diabetic kidney failure in Korean patients with type 2 diabetes mellitus. J Korean Med Sci 2007;22:810-4
  • McKnight AJ, Maxwell AP, Patterson CC, et al. Association of VEGF -1499C→T polymorphism with diabetic nephropathy in type 1 diabetes mellitus. J Diabetes Complications 2007;21:242-5
  • Haviv YS, Shpichinetsky V, Goldschmidt N, et al. The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients. Nephron 2002;92:120-6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.